• Home
  • About Us
  • Technology
  • Pipeline
  • Team
  • Partnerships
  • Media
  • Publications
  • Contact Us
HDT Bio

Suppression of hepatitis B virus through therapeutic activation of RIG-I and IRF3 signaling in hepatocytes — PubMed (nih.gov)

Jan 4, 2021 | Publications-Activate

Click here to view...

Spatiotemporal dynamics of innate immune signaling via RIG-I-like receptors — PubMed (nih.gov)

Jul 7, 2020 | Publications-Activate

Click here to view...

Beyond sensing: Retinoic acid inducible gene-I (RIG-I) continues to expand its antiviral effector functions — PubMed (nih.gov)

Jun 6, 2017 | Publications-Activate

Click here to view...

Recent Posts

  • Fierce Biotech: NIH establishes pandemic preparedness network, plans up to $100M in yearly funding for work on new treatments and vaccines
  • HDT Bio to Help Spearhead RNA Vaccine Development in National Pandemic Preparedness Initiative
  • HDT Bio Publishes Peer-Reviewed Article Describing the Development of an RNA Vaccine to Prevent Infection and Disease Caused by Enterovirus D68
  • A self-amplifying RNA vaccine prevents enterovirus D68 infection and disease in preclinical models – Science Translational Medicine
  • Bioprocess Online Live: Capital, Manufacturing Market Acceptance Of Therapeutic Cancer Vaccines

Recent Comments

No comments to show.

Privacy Policy

Terms of Use

©2024 HDT Bio

  • Follow
  • Follow